Nanomedicine / Sep 01, 2016

Hadla, M., Palazzolo, S., Corona, G., Caligiuri, I., Canzonieri, V., Toffoli, G., & Rizzolio, F. (2016). Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. Nanomedicine, 11(18), 2431–2441. https://doi.org/10.2217/nnm-2016-0154

Current Medicinal Chemistry / Dec 03, 2018

Bayda, S., Hadla, M., Palazzolo, S., Riello, P., Corona, G., Toffoli, G., & Rizzolio, F. (2018). Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic. Current Medicinal Chemistry, 25(34), 4269–4303. https://doi.org/10.2174/0929867325666171229141156

Current Medicinal Chemistry / Dec 03, 2018

Palazzolo, S., Bayda, S., Hadla, M., Caligiuri, I., Corona, G., Toffoli, G., & Rizzolio, F. (2018). The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes. Current Medicinal Chemistry, 25(34), 4224–4268. https://doi.org/10.2174/0929867324666170830113755

Nanomedicine / Oct 01, 2015

Toffoli, G., Hadla, M., Corona, G., Caligiuri, I., Palazzolo, S., Semeraro, S., Gamini, A., Canzonieri, V., & Rizzolio, F. (2015). Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin. Nanomedicine, 10(19), 2963–2971. https://doi.org/10.2217/nnm.15.118

Journal of Controlled Release / Feb 01, 2017

Bayda, S., Hadla, M., Palazzolo, S., Kumar, V., Caligiuri, I., Ambrosi, E., Pontoglio, E., Agostini, M., Tuccinardi, T., Benedetti, A., Riello, P., Canzonieri, V., Corona, G., Toffoli, G., & Rizzolio, F. (2017). Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy. Journal of Controlled Release, 248, 144–152. https://doi.org/10.1016/j.jconrel.2017.01.022

Cancers / Dec 12, 2019

Palazzolo, S., Hadla, M., Russo Spena, C., Caligiuri, I., Rotondo, R., Adeel, M., Kumar, V., Corona, G., Canzonieri, V., Toffoli, G., & Rizzolio, F. (2019). An Effective Multi-Stage Liposomal DNA Origami Nanosystem for In Vivo Cancer Therapy. Cancers, 11(12), 1997. https://doi.org/10.3390/cancers11121997

ACS Medicinal Chemistry Letters / Jan 31, 2019

Palazzolo, S., Hadla, M., Spena, C. R., Bayda, S., Kumar, V., Lo Re, F., Adeel, M., Caligiuri, I., Romano, F., Corona, G., Canzonieri, V., Toffoli, G., & Rizzolio, F. (2019). Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin. ACS Medicinal Chemistry Letters, 10(4), 517–521. https://doi.org/10.1021/acsmedchemlett.8b00557

Journal of Cellular Physiology / Sep 28, 2015

Kumar, V., Bayda, S., Hadla, M., Caligiuri, I., Russo Spena, C., Palazzolo, S., Kempter, S., Corona, G., Toffoli, G., & Rizzolio, F. (2015). Enhanced Chemotherapeutic Behavior of Open‐Caged DNA@Doxorubicin Nanostructures for Cancer Cells. Journal of Cellular Physiology, 231(1), 106–110. Portico. https://doi.org/10.1002/jcp.25057

J. Mater. Chem. B / Jan 01, 2015

Sponchia, G., Ambrosi, E., Rizzolio, F., Hadla, M., Tedesco, A. D., Spena, C. R., Toffoli, G., Riello, P., & Benedetti, A. (2015). Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications. J. Mater. Chem. B, 3(36), 7300–7306. https://doi.org/10.1039/c5tb01424g

Cancers / Oct 28, 2020

Palazzolo, S., Memeo, L., Hadla, M., Duzagac, F., Steffan, A., Perin, T., Canzonieri, V., Tuccinardi, T., Caligiuri, I., & Rizzolio, F. (2020). Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery Nanotools. Cancers, 12(11), 3165. https://doi.org/10.3390/cancers12113165

Scientific Reports / Nov 16, 2022

Rovito, R., Bono, V., Augello, M., Tincati, C., Mainoldi, F., Beaudoin-Bussières, G., Tauzin, A., Bianchi, S., Hadla, M., Yellenki, V., d’Arminio Monforte, A., Casola, S., Borghi, E., Finzi, A., & Marchetti, G. (2022). Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-23923-1

Fundamentals of Quorum Sensing, Analytical Methods and Applications in Membrane Bioreactors / Jan 01, 2018

Hadla, M., & Halabi, M. A. (2018). Effect of Quorum Sensing. In Comprehensive Analytical Chemistry (pp. 95–116). Elsevier. https://doi.org/10.1016/bs.coac.2018.02.004

Cancer Research / Jul 15, 2016

Rizzolio, F., Hadla, M., Corona, G., Caligiuri, I., Palazzolo, S., Semeraro, S., Gamini, A., Canzonieri, V., & Toffoli, G. (2016). Abstract 2205: Exosomal encapsulation of doxorubicin reduces the cardiac toxicity of mice. Cancer Research, 76(14_Supplement), 2205–2205. https://doi.org/10.1158/1538-7445.am2016-2205

Bacterial Empire / Jun 29, 2021

GERGES, C., HADLA, M., ELIALI, M., RICHA, M., Mammari, N., & HALABI, M. A. (2021). ANTIBACTERIAL ACTIVITY OF SOAP MADE FROM ESSENTIAL OILS AND COMMERCIAL SOAP SOLD IN THE LEBANESE MARKET. Bacterial Empire, e304. https://doi.org/10.36547/be.304

Biostimulants for sustainable crop production / Jul 28, 2020

Ertani, A., Schiavon, M., & Nardi, S. (2020). Humic substances (HS) as plant biostimulants in agriculture. In Burleigh Dodds Series in Agricultural Science (pp. 55–76). Burleigh Dodds Science Publishing. https://doi.org/10.19103/as.2020.0068.04

Biomedicines / Dec 14, 2022

Galassi, A., Ciceri, P., Bono, V., Magagnoli, L., Sala, M., Artioli, L., Rovito, R., Hadla, M., Yellenki, V., D’Arminio Monforte, A., Tincati, C., Cozzolino, M., & Marchetti, G. (2022). Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19. Biomedicines, 10(12), 3251. https://doi.org/10.3390/biomedicines10123251

Nephrology Dialysis Transplantation / May 01, 2022

Ciceri, P., Bono, V., Magagnoli, L., Sala, M., Artioli, L., Rovito, R., Hadla, M., Yellenki, V., D’arminio Monforte, A., Galassi, A., Tincati, C., Marchetti, G., & Gennaro Cozzolino, M. (2022). MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection. Nephrology Dialysis Transplantation, 37(Supplement_3). https://doi.org/10.1093/ndt/gfac070.023